Cargando…
NAFLD Preclinical Models: More than a Handful, Less of a Concern?
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver diseases ranging from simple steatosis to non-alcoholic steatohepatitis, fibrosis, cirrhosis, and/or hepatocellular carcinoma. Due to its increasing prevalence, NAFLD is currently a major public health concern. Although a wide variety...
Autores principales: | Oligschlaeger, Yvonne, Shiri-Sverdlov, Ronit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167756/ https://www.ncbi.nlm.nih.gov/pubmed/32046285 http://dx.doi.org/10.3390/biomedicines8020028 |
Ejemplares similares
-
Inflammatory Bowel Disease: A Stressed “Gut/Feeling”
por: Oligschlaeger, Yvonne, et al.
Publicado: (2019) -
Plasma Cathepsin D Activity Rather Than Levels Correlates With Metabolic Parameters of Type 2 Diabetes in Male Individuals
por: Ding, Lingling, et al.
Publicado: (2020) -
Plasma cathepsin D activity is negatively associated with hepatic insulin sensitivity in overweight and obese humans
por: Ding, Lingling, et al.
Publicado: (2019) -
MSP is a negative regulator of inflammation and lipogenesis in ex vivo models of non-alcoholic steatohepatitis
por: Chanda, Dipanjan, et al.
Publicado: (2016) -
Inhibiting Extracellular Cathepsin D Reduces Hepatic Steatosis in Sprague–Dawley Rats †
por: Khurana, Princy, et al.
Publicado: (2019)